Akeso Announces First Patient Dose in Global Registrational Trial of Cadonilimab (PD-1/CTLA-4) for PD-1 Treatment-Resistant Hepatocellular Carcinoma
HONG KONG, Sept. 15, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced that the first patient has been... Read more.
Gary Vaynerchuk Joins Stan Store, Backing the Platform Redefining the $250 Bn Creator Economy
Gary Vaynerchuk becomes an Investor in Stan Store – the platform powering 80,000+ Creators who’ve generated $300M in sales in the last three years. Stan... Read more.
ORANGE EV AND OPTIGRID UNVEIL THE ORANGE JUICER™ BATTERY-INTEGRATED DC FAST CHARGER
Cuts fleet electrification timelines from years to weeks Removes high infrastructure costs Delivers full charging performance with up to 85% less grid input power... Read more.
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation ‘Data Mining Machine’ for Genomics
SHENZHEN, China, Sept. 14, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation... Read more.
BCI Shines at the RE+2025 Energy Expo in Las Vegas
LAS VEGAS, Sept. 14, 2025 /PRNewswire/ — BCI, an Indonesian solar cell manufacturer, achieved remarkable success at the 2025 RE+ Expo held in Las Vegas from... Read more.
Open Cooperation Forum at China International Fair for Trade in Services 2025 Held
Openness and Collaboration for a Shared Future BEIJING, Sept. 14, 2025 /PRNewswire/ — The China International Fair for Trade in Services (CIFTIS), the largest... Read more.
FWD GROUP HOLDINGS LIMITED LAUNCH OF TENDER OFFER
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation... Read more.
Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101
SHANGHAI and SUZHOU, China, Sept. 14, 2025 /PRNewswire/ — Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug... Read more.
Lion TCR Achieves Triple FDA Milestones with IND Clearance for Chronic Hepatitis B Following Earlier Fast Track and Orphan Drug Designations
SINGAPORE and GUANGZHOU, China, Sept. 14, 2025 /PRNewswire/ — Lion TCR, a clinical-stage biotechnology company pioneering T-cell receptor (TCR)-based therapies,... Read more.
Armor Health Announces Partnership with Antidote-AI to Revolutionize Correctional Healthcare Landscape
MIAMI, Sept. 14, 2025 /PRNewswire/ — Armor Health (ArmorHealthcare.com), today announced it’s new partnership with Antidote-AI (Antidote-AI.com) as their... Read more.